Initiation of an inter-hospital extracorporeal membrane oxygenation transfer programme for critically ill patients with coronavirus disease 2019: bringing extracorporeal membrane oxygenation support to peripheral hospitals.
Adult
COVID-19
/ therapy
Critical Care
/ organization & administration
Extracorporeal Membrane Oxygenation
Female
Hospitals, University
Humans
Male
Middle Aged
Patient Transfer
/ organization & administration
Retrospective Studies
SARS-CoV-2
Transportation of Patients
/ organization & administration
Acute respiratory distress syndrome
COVID-19
Extracorporeal membrane oxygenation
Pneumonia
Journal
Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399
Informations de publication
Date de publication:
10 05 2021
10 05 2021
Historique:
received:
02
09
2020
revised:
31
10
2020
accepted:
09
11
2020
pubmed:
2
3
2021
medline:
21
5
2021
entrez:
1
3
2021
Statut:
ppublish
Résumé
Extracorporeal membrane oxygenation (ECMO) is a resource-intensive, highly specialized and expensive therapy that is often reserved for high-volume centres. In recent years, we established an inter-hospital ECMO transfer programme that enables ECMO implants in peripheral hospitals. During the pandemic, the programme was expanded to include ECMO support in selected critically ill patients with coronavirus disease 2019 (COVID-19). This retrospective single-centre study reports the technical details and challenges encountered during our initial experience with ECMO implants in peripheral hospitals for patients with COVID-19. During March and April 2020, our team at the University Hospital of Zurich performed 3 out-of-centre ECMO implants at different peripheral hospitals. The implants were performed without any complications. The patients were transported by ambulance or helicopter. Good preparation and selection of the required supplies are the keys to success. The implant should be performed by a well-trained, seasoned ECMO team, because options are limited in most peripheral hospitals. Out-of-centre ECMO implants in well-selected patients with COVID-19 is feasible and safe if a well-established organization is available and if the implantation is done by an experienced and regularly trained team.
Identifiants
pubmed: 33647975
pii: 6153949
doi: 10.1093/icvts/ivaa326
pmc: PMC7989441
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
812-816Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.